227 companies|as of 04/06/2026|gov bond yield: 4.49%|erp: 4.75%|unlevered beta: 0.96|relevered beta: 0.96
Inhibrx Biosciences15.00%
CareDx13.94%
Alphamab Oncology13.88%
Everest Medicines13.75%
Mind Medicine (MindMed)13.36%
Oxford Biomedica13.28%
Beam Therapeutics13.21%
Twist Bioscience13.11%
Sana Biotechnology12.90%
Neuren Pharmaceuticals12.87%
Adaptive Biotechnologies12.84%
HBM Holdings12.65%
Immunome12.60%
Kymera Therapeutics12.50%
Kodiak Sciences12.46%
Imeik Technology Development12.35%
Veracyte12.33%
Rhythm Pharmaceuticals12.15%
Intellia Therapeutics12.14%
Nurix Therapeutics12.00%
Protagonist Therapeutics11.93%
Vitrolife11.93%
Relay Therapeutics11.62%
CRISPR Therapeutics11.56%
WuXi Biologics (Cayman)11.42%
Wuhan Keqian Biology11.33%
TG Therapeutics11.24%
Mabwell (Shanghai) Bioscience11.23%
Monte Rosa Therapeutics11.18%
Hualan Biological Bacterin11.17%
Pharmaron Beijing11.13%
CureVac11.12%
Porton Pharma Solutions11.11%
Gan & Lee Pharmaceuticals11.03%
Chengdu Kanghua Biological Products11.03%
Natera11.01%
Mesoblast10.89%
Nuvation Bio10.89%
BGI Genomics10.89%
Arcutis Biotherapeutics10.88%
Amoy Diagnostics10.74%
MiMedx Group10.73%
Cidara Therapeutics10.67%
Chengdu Olymvax Biopharmaceuticals10.63%
Aurinia Pharmaceuticals10.56%
Staidson (Beijing) BioPharmaceuticals10.55%
Revolution Medicines10.54%
Ascletis Pharma10.52%
Jinyu Bio-technology10.44%
Novo Nordisk10.31%
Beijing Hotgen Biotech10.27%
Bio-Techne10.26%
Hebei Changshan Biochemical Pharmaceutical10.26%
Anhui Anke Biotechnology (Group)10.24%
Immatics10.23%
Hualan Biological Engineering10.18%
Abbisko Cayman10.17%
Arrowhead Pharmaceuticals10.15%
CARsgen Therapeutics Holdings10.07%
Asymchem Laboratories (Tianjin)10.04%
Vaxcyte10.03%
InnoCare Pharma10.00%
Shanghai Allist Pharmaceuticals9.98%
Ligand Pharmaceuticals9.94%
Chongqing Zhifei Biological Products9.93%
Nektar Therapeutics9.89%
Wedge Industrial9.89%
Dianthus Therapeutics9.86%
Jiangxi Fushine Pharmaceutical9.86%
Tango Therapeutics9.85%
Gubra9.80%
AbCellera Biologics9.80%
Sunshine Guojian Pharmaceutical (Shanghai)9.79%
Stoke Therapeutics9.78%
Nuvalent9.77%
3SBio9.71%
Zymeworks9.70%
Exact Sciences9.68%
Roivant Sciences9.67%
Merus9.66%
Travere Therapeutics9.66%
Piramal Pharma9.63%
Vericel9.61%
Hunan Jiudian Pharmaceutical9.59%
Dyne Therapeutics9.54%
MedinCell9.48%
Vcanbio Cell & Gene Engineering9.47%
Precigen9.44%
Anhui Huaheng Biotechnology9.40%
CStone Pharmaceuticals9.39%
Moderna9.39%
Sinocelltech Group9.39%
Syngene International9.38%
MoonLake Immunotherapeutics9.36%
Genus9.35%
Recursion Pharmaceuticals9.35%
Zhejiang Jolly Pharmaceutical9.34%
Denali Therapeutics9.33%
Shanghai Junshi Biosciences9.28%
Youcare Pharmaceutical Group9.25%
Avidity Biosciences9.23%
RemeGen9.22%
Beijing Wantai Biological Pharmacy Enterprise9.22%
Chengzhi Shareholding9.17%
Lepu Biopharma9.13%
Beijing Strong Biotechnologies9.12%
Harmony Biosciences Holdings9.09%
Celldex Therapeutics9.08%
Financière de Tubize9.06%
Suzhou Zelgen Biopharmaceuticals9.06%
Ascentage Pharma9.04%
Shijiazhuang Yiling Pharmaceutical9.04%
ARS Pharmaceuticals9.03%
Telix Pharmaceuticals9.02%
Vera Therapeutics9.02%
Disc Medicine9.00%
Sinopep-Allsino Bio Pharmaceutical9.00%
Xencor8.98%
Viridian Therapeutics8.95%
UCB8.90%
Ocular Therapeutix8.90%
Zealand Pharma8.87%
Guilin Sanjin Pharmaceutical8.82%
Daan Gene8.81%
Tibet Cheezheng Tibetan Medicine8.79%
Sino Biopharmaceutical8.77%
Arcus Biosciences8.76%
ACADIA Pharmaceuticals8.72%
BridgeBio Pharma8.71%
Pharma Mar8.68%
Insmed8.57%
Shanghai Haohai Biological Technology8.56%
Incyte8.56%
Tyra Biosciences8.52%
Innovent Biologics8.51%
Shanghai Henlius Biotech8.51%
Immunovant8.48%
Oxford Nanopore Technologies8.47%
MannKind8.47%
argenx8.44%
Catalyst Pharmaceuticals8.42%
Kuros Biosciences8.42%
Erasca8.40%
ADMA Biologics8.36%
Keymed Biosciences8.32%
Yantai Dongcheng Pharmaceutical Group8.31%
Biocytogen Pharmaceuticals (Beijing)8.28%
Genscript Biotech8.25%
Akeso8.19%
Ardelyx8.15%
Xenon Pharmaceuticals8.07%
Axsome Therapeutics8.00%
Xiamen Amoytop Biotech8.00%
China Resources Boya Bio-pharmaceutical Group8.00%
Haisco Pharmaceutical Group7.95%
Agios Pharmaceuticals7.93%
Halozyme Therapeutics7.91%
Liquidia7.90%
Xeris Biopharma Holdings7.89%
United Therapeutics7.88%
Bonesupport Holding7.87%
Biocon7.86%
Simcere Pharmaceutical Group7.84%
ALK-Abelló7.80%
Krystal Biotech7.75%
Mirum Pharmaceuticals7.71%
Shanghai RAAS Blood Products7.71%
Nanobiotix7.68%
Corcept Therapeutics7.64%
Tarsus Pharmaceuticals7.63%
Beijing Tiantan Biological Products7.56%
Chengdu Easton Biopharmaceuticals7.56%
SK bioscience7.51%
Idorsia7.51%
PTC Therapeutics7.41%
Exelixis7.38%
Amicus Therapeutics7.35%
RAPT Therapeutics7.31%
Camurus7.31%
Syndax Pharmaceuticals7.30%
AnaptysBio7.28%
Ionis Pharmaceuticals7.27%
Cytokinetics7.24%
Cogent Biosciences7.18%
Innoviva7.18%
Genmab7.15%
Alkermes7.14%
SK Biopharmaceuticals7.12%
BioCryst Pharmaceuticals7.08%
Zhejiang Ausun Pharmaceutical7.06%
Vertex Pharmaceuticals7.05%
Celltrion7.03%
Enliven Therapeutics7.02%
Alnylam Pharmaceuticals6.97%
Inner Mongolia Furui Medical Science6.95%
Edgewise Therapeutics6.93%
Savara6.90%
Samsung Biologics6.86%
Crinetics Pharmaceuticals6.86%
BioMarin Pharmaceutical6.86%
Regeneron Pharmaceuticals6.85%
Bavarian Nordic6.84%
CSL6.83%
Laboratorios Farmaceuticos Rovi6.82%
Aurisco Pharmaceutical6.82%
PeptiDream6.67%
Royalty Pharma6.65%
Ultragenyx Pharmaceutical6.63%
Sarepta Therapeutics6.61%
Arcellx6.59%
Jazz Pharmaceuticals6.56%
Oculis Holding6.53%
Celcuity6.49%
Kiniksa Pharmaceuticals6.45%
Soleno Therapeutics6.43%
Phathom Pharmaceuticals6.35%
NewAmsterdam Pharma Company6.33%
GC Biopharma6.17%
CK Life Sciences Int'l., (Holdings)5.97%
IDEAYA Biosciences5.93%
Philogen5.61%
Amylyx Pharmaceuticals5.59%
Galapagos5.45%
Pharming Group5.40%
Oruka Therapeutics5.32%
Apellis Pharmaceuticals5.30%
Wave Life Sciences1.89%
methodology
WACC is calculated as the weighted average of the cost of equity and the after-tax cost of debt, using median unlevered betas (5-year monthly, adjusted via Blume) relevered with median net-debt capital structures via the Hamada equation.
Cost of equity = risk-free rate + relevered beta × equity risk premium. Cost of debt = (risk-free rate + credit spread) × (1 − tax rate).
Data is updated daily. Read our full methodology on the sources page.